Can we differentiate between music composed by Humans versus Artificial Intelligence? (This is the title of the paper)
- Formulate a research question which is professionally or personally relevant, and design a project to answer this
Choose a topic related to the music industry and/or your personal development/professional practice
Plan a research project, taking into account ethical considerations
- Demonstrate that you have read about your topic, and can put your project in context through secondary research
Situate the project in relation to relevant academic research on the topic. Include examples of practical, editorial or biographical material where appropriate.
Explain why your project is relevant and worthy of inquiry.
- Plan and carry out relevant primary research, showing engagement with research theory
Explain and justify the project methodology using credible academic textbooks on research methods.
Carry out appropriate primary research based on this.
- Critically reflect on the design, progress and outcomes of your research
Discuss your project findings, and justify the conclusions you draw from these.
Critically evaluate the strengths and weaknesses of the project.
It is apparent that the United States has a problem, but what are some solutions to to this crisis? Unfortunately, there is no simple solution to this complex problem, but in order to move forward, we propose several methods that may incite change in the current system in place. Historically, pharmaceutical companies dictate pricing with no restrictions from Medicare, Medicaid, or Federal/State governments. The US government (i.e. Medicare, Medicaid, Tricare, etc.) is the largest buyer of prescription drugs in the world, yet they have no say in the pricing of drugs. Our government also generally issues funds to these pharmaceutical companies for research and development, with substantial investments in the basic science that leads to new drug discoveries. For example, the federal government spent $484 million developing the cancer drug Taxol, which was then taken under agreement with Bristol-Myers Squibb in 1993. In 10 years, the manufacturer earned $9 billion in revenue and paid the federal government $35 million in royalties (article). Although 75% of new innovative drugs are supported by federal funding, most consumers and payers are unable to afford these medications due to the unreasonable prices. (article) We propose for the United States government to have the ability to establish delegated sectors to negotiate drug prices. By giving the government some power in dictating cost, this could substantially lower introductory prices, annual costs, and which may reduce out-of-pocket costs for patients. For example, the government may establish a drug’s ceiling price similar to the Federal Ceiling Price program used by the Department of Veteran Affairs. They may also begin use of reference pricing, thus permitting the Department of Health and Human Services to set a benchmark price for clinically comparable drugs that are interchangeable. Though these changes may produce more cost-effective medication, a drawback may be the lack of market diversity. Rather than having one pharmaceutical company dictating the price, the federal government is dictating the price thus creating a lack of competition. Having one body dictate everything may create tensions between pharmaceutical companies and the government; thus, chan>GET ANSWER